肥胖与根治性前列腺切除术后生化复发风险及PSA倍增时间:SEARCH数据库结果
基于SEARCH数据库4123例1988至2015年间接受根治性前列腺切除术的男性,分析BMI与生化复发(BCR)及复发后PSA倍增时间(PSADT)的关联。多因素校正后,较高BMI与BCR风险升高显著相关(P=0.008);但在BCR患者中,四个BMI类别的校正PSADT值相似(20.9 vs 21.3 vs 21.0 vs 14.9个月,P=0.48)。结论认为肥胖与BCR风险相关,但未发现BMI与复发时PSADT的关联,提示肥胖男性复发未必更具侵袭性。
要点
- 较高BMI与根治性前列腺切除术后生化复发风险升高独立相关。
- 在发生生化复发的患者中,不同BMI类别的PSA倍增时间无显著差异。
- 数据提示肥胖男性复发后的侵袭性未必更强,需进一步研究肥胖对挽救治疗反应的影响。
核心结论
- 较高BMI与根治性前列腺切除术后生化复发风险升高显著相关,但BMI与复发时PSA倍增时间无关。
研究设计与样本
- 基于SEARCH数据库的回顾性队列研究,纳入4123例1988至2015年间接受根治性前列腺切除术且数据完整的男性。
主要发现
- 922例(22%)正常体重(BMI<25 kg/m2),1863例(45%)超重(BMI 25-29.9 kg/m2),968例(24%)肥胖(BMI 30-34.9 kg/m2),370例(9%)中度或重度肥胖(BMI≥35 kg/m2)。
- 多因素校正年龄、种族、PSA、穿刺Gleason评分、临床分期、年份和手术中心后,较高BMI与BCR风险升高显著相关(P=0.008)。
- 在BCR患者中,四个BMI类别的多因素校正PSADT值相似(随BMI类别升高分别为20.9、21.3、21.0、14.9个月;P=0.48)。
临床怎么用
- 临床中可将较高BMI视为根治性前列腺切除术后生化复发的风险因素进行关注。
- 对于肥胖且发生生化复发的患者,不应仅凭BMI判断复发侵袭性更强,PSA倍增时间评估仍需常规进行。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine the association between body mass index (BMI) and aggressive biochemical recurrence (BCR) using the Shared Equal Access Regional Cancer Hospital (SEARCH) database. MATERIAL AND METHODS: We identified 4123 men with complete data treated by radical prostatectomy between 1988 and 2015. We tested the association between BMI and BCR using Cox models, and among men with BCR, prostate-specific antigen doubling time (PSADT) was compared across BMI categories using linear regression. Models were adjusted for age, race, prostate-specific antigen, biopsy Gleason score, clinical stage, year and surgical centre. RESULTS: Overall, 922 men (22%) were of normal weight (BMI <25 kg/m2 ), 1863 (45%) were overweight (BMI 25-29.9 kg/m2 ), 968 (24%) were obese (BMI 30-34.9 kg/m2 ), and 370 (9%) were moderately or severely obese (BMI ≥35 kg/m2 ). After adjustment for multiple clinical characteristics, higher BMI was significantly associated with higher risk of BCR (P = 0.008). Among men with BCR, men in the four BMI categories had similar multivariable-adjusted PSADT values (increasing BMI categories: 20.9 vs 21.3 vs 21.0 vs 14.9 months; P = 0.48). CONCLUSION: While we confirmed that higher BMI was associated with BCR, we found no link between BMI and PSADT at the time of recurrence. Our data suggest obese men do not have more aggressive recurrences. Future studies are needed to test whether obesity predicts response to salvage therapies.
引用
- Freedland SJ, Branche BL, Howard LE, et al. Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. BJU Int. 2018. PMID: 30347135. doi:10.1111/bju.14594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。